)
)
Asarina Pharma Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Asarina Pharma
Access all reports
Asarina Pharma AB is a Swedish biotechnology company specializing in the development of Sepranolone, a compound designed to treat stress, compulsivity, and neurological disorders related to Allopregnanolone. This neurosteroid is implicated in conditions such as Tourette syndrome, Obsessive-Compulsive Disorder (OCD), and Premenstrual Dysphoric Disorder (PMDD). Asarina Pharma's focus is on innovative treatments that modulate the effects of Allopregnanolone, aiming to provide safer and more effective therapeutic options. The company is headquartered in Solna, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
ASAP
Country
🇸🇪 Sweden